• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Few patients with prostate cancer are willing to be randomised to treatment.很少有前列腺癌患者愿意被随机分配接受治疗。
BMJ. 1999 Jun 5;318(7197):1556. doi: 10.1136/bmj.318.7197.1556a.
2
Experiences of randomization: interviews with patients and clinicians in the SPCG-IV trial.随机化的经历：对SPCG-IV试验中的患者和临床医生的访谈
Scand J Urol Nephrol. 2008;42(4):358-63. doi: 10.1080/00365590801950253.
3
Early closure of a randomized controlled trial of three treatment approaches to early localised prostate cancer: the MRC PR06 trial.早期局限性前列腺癌三种治疗方法随机对照试验的提前终止：MRC PR06试验
BJU Int. 2004 Dec;94(9):1400-1. doi: 10.1111/j.1464-410X.2004.05224_3.x.
4
The Scandinavian Prostate Cancer Group Study: the case for conservative management.斯堪的纳维亚前列腺癌研究小组研究：保守治疗的依据
BJU Int. 2005 Nov;96(7):952-3. doi: 10.1111/j.1464-410X.2005.05794.x.
5
Preference-based intervention in prostate cancer.基于偏好的前列腺癌干预措施。
Lancet Oncol. 2019 Apr;20(4):e199. doi: 10.1016/S1470-2045(19)30186-X. Epub 2019 Mar 22.
6
[PREFERE - a chance for research and patients].[PREFERE——一个研究与患者的契机]
Aktuelle Urol. 2014 Mar;45(2):98. doi: 10.1055/s-0034-1373687. Epub 2014 Apr 3.
7
'Time, gentlemen, please' for watchful waiting in prostate cancer?
BJU Int. 2007 Aug;100(2):244-6. doi: 10.1111/j.1464-410X.2007.07063.x. Epub 2007 Jun 5.
8
'ProtecTion' from overtreatment: does a randomized trial finally answer the key question in localized prostate cancer?避免过度治疗的“保护”：一项随机试验最终能否回答局限性前列腺癌的关键问题？
BJU Int. 2017 Apr;119(4):513-514. doi: 10.1111/bju.13734. Epub 2017 Jan 4.
9
Screening for prostate cancer remains controversial.前列腺癌筛查仍然存在争议。
BMJ. 2009 Sep 24;339:b3601. doi: 10.1136/bmj.b3601.
10
Screening for prostate cancer. Randomised trials of treatment in early disease are important.前列腺癌筛查。早期疾病治疗的随机试验很重要。
BMJ. 1997 Jul 19;315(7101):186-7. doi: 10.1136/bmj.315.7101.186b.

引用本文的文献

1
Oncologic Outcomes of Radical Prostatectomy and High-Dose Intensity-Modulated Radiotherapy with Androgen-Deprivation Therapy for Relatively Young Patients with Unfavorable Intermediate-Risk Prostate Adenocarcinoma.根治性前列腺切除术及高剂量调强放疗联合雄激素剥夺治疗相对年轻的预后不良中危前列腺腺癌患者的肿瘤学结局
Cancers (Basel). 2021 Mar 25;13(7):1517. doi: 10.3390/cancers13071517.
2
Combined Modality Therapies for High-Risk Prostate Cancer: Narrative Review of Current Understanding and New Directions.高危前列腺癌的综合治疗：当前认识与新方向的叙述性综述
Front Oncol. 2019 Nov 29;9:1273. doi: 10.3389/fonc.2019.01273. eCollection 2019.
3
Current prostate cancer treatment: Not what but when?当前前列腺癌的治疗：不是治疗什么，而是何时治疗？
Can Urol Assoc J. 2016 Aug;10(7-8):251-252. doi: 10.5489/cuaj.4018.
4
Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation.极高风险局限性前列腺癌：根治性放疗后的结局
Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):254-62. doi: 10.1016/j.ijrobp.2015.10.056. Epub 2015 Oct 31.
5
Can we deliver randomized trials of focal therapy in prostate cancer?我们能否在前列腺癌中开展局部治疗的随机临床试验？
Nat Rev Clin Oncol. 2014 Aug;11(8):482-91. doi: 10.1038/nrclinonc.2014.44. Epub 2014 Apr 22.
6
A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study.多中心前瞻性开发研究评估高强度聚焦超声治疗局限性前列腺癌：INDEX 研究。
Contemp Clin Trials. 2013 Sep;36(1):68-80. doi: 10.1016/j.cct.2013.06.005. Epub 2013 Jun 14.
7
Demographic analysis: an update of randomized controlled studies in prostatic oncology.人口统计学分析：前列腺肿瘤学随机对照研究的最新情况。
Can Urol Assoc J. 2011 Aug;5(4):248-53. doi: 10.5489/cuaj.10156.
8
Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult.质量改进报告：通过将随机试验嵌入定性研究来改进其设计与实施：前列腺癌检测与治疗（ProtecT）研究。评论：向患者提供无偏信息可能具有挑战性。
BMJ. 2002 Oct 5;325(7367):766-70. doi: 10.1136/bmj.325.7367.766.

本文引用的文献

1
Patients with prostate cancer should be enrolled in a national, controlled trial.前列腺癌患者应纳入一项全国性对照试验。
BMJ. 1999 Jan 9;318(7176):126. doi: 10.1136/bmj.318.7176.126.

Few patients with prostate cancer are willing to be randomised to treatment.

作者信息

O'Reilly P, Martin L, Collins G

出版信息

BMJ. 1999 Jun 5;318(7197):1556. doi: 10.1136/bmj.318.7197.1556a.

DOI:10.1136/bmj.318.7197.1556a
PMID:10356027
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1115919/
Abstract
摘要